Skip to main content
Fig. 3 | Journal of Nanobiotechnology

Fig. 3

From: Powering mesoporous silica nanoparticles into bioactive nanoplatforms for antibacterial therapies: strategies and challenges

Fig. 3

Reproduced with permission from Ref. [69] Copyright 2021, Elsevier B.V. B The design of CCM@SBA-15/PDA/Ag nanoparticles and their responsive drug release evaluation. C The evaluation of CCM pH, ROS response release. D To evaluate pH-responsive Ag release from nanoformulations. Reproduced with permission from Ref. [72] Copyright 2020, American Chemical Society. E The construction of Ag- and DNase I-loaded mesoporous silica and the evaluation of antibacterial and removing biofilms. Reproduced with permission from Ref. [73] Copyright 2020, RSC Pub. F The MSN design and release mechanism of dopamine chelated copper ions. Reproduced with permission from Ref. [79] Copyright 2020, Elsevier B.V. G The antibacterial and anti-biofilm activities of spiky nanocomposites synthesized by BAC and NaSal co-templates. Reproduced with permission from Ref. [88] Copyright 2022, Shanghai Jiao Tong Univ Press. H Illustration of the viral type and smooth MSN loaded with LL-37, and free LL-37 interaction with the cell membrane. Reproduced with permission from Ref. [94] Copyright 2021, American Chemical Society. I The T7E21R-HD5 structure and the design process of MSN@T7E21R@HD5@SCN. Reproduced with permission from Ref. [95] Copyright 2019, The Royal Society of Chemistry

A Cefepime or meropenem loaded amine-functionalized mesoporous silica nanoparticles (MSN-NH2-CEF/MEP) against Acinetobacter baumannii.

Back to article page